Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

596 Articles

Chris Lange | Oct 25, 2019 at 9:59 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Oct 10, 2019 at 9:40 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The September 30 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 25, 2019 at 9:20 AM EDT

Short Sellers Grow More Selective in Big Pharma

The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 28, 2019 at 11:20 AM EDT

7 Giant Mergers Transforming the Face of Corporate America

Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 26, 2019 at 3:20 PM EDT

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 7, 2019 at 11:15 AM EDT

Defensive Stocks Standing Strong as Broader Stock Market Indexes Tank

24/7 Wall St. has taken a look at the defensive stocks that are holding up fine on a day that…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 12 13 14 15 16 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Can’t Make Up Their Minds on Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

7 Giant Mergers Transforming the Face of Corporate America

Big Pharma Sees a Rising Tide in Short Interest

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Defensive Stocks Standing Strong as Broader Stock Market Indexes Tank

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Short Sellers Can’t Make Up Their Minds on Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Short Sellers Grow More Selective in Big Pharma

Short Sellers Can’t Make Up Their Minds on Big Pharma

7 Giant Mergers Transforming the Face of Corporate America

Big Pharma Sees a Rising Tide in Short Interest

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Defensive Stocks Standing Strong as Broader Stock Market Indexes Tank

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Featured Reads

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62